GFOR Chart
See on advanced chart >
About
NKGen Biotech, Inc.is a clinical-stage biotechnology company incorporated as a Delaware corporation developing cell therapies for neurodegenerative and oncological diseases based on activated natural killer ("NK") cells. NKGen's product candidates are based...
Read More
- HighlightA clinical-stage biotechnology company focused on autologous, allogeneic and CAR-NK natural killer cell therapies
- ExchangeNYSE
- Listing Date07/13/2021
- Established DateInvalid Date
- Full-time Employees63
- Address3001 Daimler St Santa Ana California 92705
- Tel1-949-3966830
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry